MesotheliomaPhase 1NCT06885697
TNhYP218 CAR T Cells
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
Ph1/2 Trial Of Navlimetostat With Pumitamig In MTAP-Deficient Advanced Non-Small Cell Lung Cancer
What the film says
This trial is for adults with advanced non-small cell lung cancer whose tumors lack a gene called MTAP.
The idea: combine navlimetostat, a pill taken once a day, with pumitamig, given by infusion. Tumors that lack MTAP may be especially sensitive to navlimetostat.
The study looks for a safe dose of the combination, and at how well it works.
This phase 1 and 2 study plans 17 patients. At MD Anderson Cancer Center in Houston, Natalie Vokes leads it.
Public record; not medical advice.
Sources behind this film
Adults; MTAP-deficient advanced NSCLC; Navlimetostat once daily pill; pumitamig infusion; MTAP-loss sensitivity; Safe dose; effectiveness (+1 more lines)
The drug
Primary Objectives: Phase I: To evaluate the safety of navlimetostat in combination with pumitamig. Phase II: To evaluate the efficacy of navlimetostat in combination with pumitamig.
Secondary Objectives: * To evaluate toxicity and tolerability of navlimetostat in combination with pumitamig. * To evaluate efficacy outcomes including disease control rate, progression-free survival, overall survival, and duration of response. * To compare the efficacy of the combination in patients with prior ICI exposure and those without (treated with targeted therapy and/or chemotherapy).
The study
The goal of this clinical research study is to find a safe and tolerable dose of navlimetostat in combination with pumitamig that can be given to patients with MTAP-deficient advanced non-small cell lung cancer (NSCLC). The effectiveness of the study drugs will also be studied.
Eligibility
Inclusion criteria as written on the registry, trimmed. The full list, with exclusions, is on the live record.
For you, or someone you love
A complex diagnosis brings new questions every week, in a trial and out of one. Triangle keeps your whole medical file together, reads it with you in plain language, and helps you and your family decide what to ask next.
Then $9 a month. Cancel anytime.
Requested from your hospitals and clinics through the national networks. Add scans, pathology and anything on paper.
Reports explained as they come in, with lab values you can follow before treatment, during a trial and after.
Ask about your own file, and walk in with questions for your oncologist or the trial team.
Share one profile with the family helping you, and with your doctors.
Members also get a deeper analysis of their records and any sequencing data, including clinical trials that may fit, reviewed by a licensed physician before they receive it.
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.
How these trials work: what Phase 1 actually is · common questions Not clinical evidence.